Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

Kolbert KS, Pentlow KS, Pearson JR, Sheikh A, Finn RD, Humm JL, Larson SM.

J Nucl Med. 2007 Jan;48(1):143-9.

PMID:
17204711
[PubMed - indexed for MEDLINE]
Free Article
2.

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.

Sgouros G, Hobbs RF, Atkins FB, Van Nostrand D, Ladenson PW, Wahl RL.

Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S41-7. doi: 10.1007/s00259-011-1769-1. Epub 2011 Apr 12. Review.

PMID:
21484384
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.

Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM.

Br J Radiol. 2009 Oct;82(982):860-76. doi: 10.1259/bjr/25645894. Epub 2009 May 11. Review.

PMID:
19433487
[PubMed - indexed for MEDLINE]
4.

PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?

Hall NC, Kloos RT.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):793-805. Review.

PMID:
17891243
[PubMed - indexed for MEDLINE]
Free Article
5.

The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.

Flux G, Bardies M, Monsieurs M, Savolainen S, Strands SE, Lassmann M; EANM Dosimetry Committee.

Z Med Phys. 2006;16(1):47-59. Review.

PMID:
16696370
[PubMed - indexed for MEDLINE]
6.

[Utility of positron emission tomography with fluorodeoxyglucose (FDG-PET) in the evaluation of thyroid cancer: a systematic review].

Kuba VM, Caetano R, Coeli CM, Vaisman M.

Arq Bras Endocrinol Metabol. 2007 Aug;51(6):961-71. Review. Portuguese.

PMID:
17934664
[PubMed - indexed for MEDLINE]
Free Article
7.

Quantitative imaging of (124)I with PET/ CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections.

Jentzen W, Freudenberg L, Bockisch A.

Q J Nucl Med Mol Imaging. 2011 Feb;55(1):21-43. Review.

PMID:
21386783
[PubMed - indexed for MEDLINE]
8.

The role of (124)I-PET in diagnosis and treatment of thyroid carcinoma.

Lubberink M, Abdul Fatah S, Brans B, Hoekstra OS, Teule GJ.

Q J Nucl Med Mol Imaging. 2008 Mar;52(1):30-6. Review.

PMID:
17657202
[PubMed - indexed for MEDLINE]
9.

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

Facey K, Bradbury I, Laking G, Payne E.

Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. Review.

PMID:
17999839
[PubMed - indexed for MEDLINE]
Free Article
10.

Radioiodine imaging and treatment in thyroid disorders.

Griggs WS, Divgi C.

Neuroimaging Clin N Am. 2008 Aug;18(3):505-15, viii. doi: 10.1016/j.nic.2008.03.008. Review.

PMID:
18656031
[PubMed - indexed for MEDLINE]
11.

Positron emission tomography/computed tomography.

Townsend DW.

Semin Nucl Med. 2008 May;38(3):152-66. doi: 10.1053/j.semnuclmed.2008.01.003. Review.

PMID:
18396176
[PubMed - indexed for MEDLINE]
12.

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Lopci E, Chiti A, Castellani MR, Pepe G, Antunovic L, Fanti S, Bombardieri E.

Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S28-40. doi: 10.1007/s00259-011-1772-6. Epub 2011 Apr 12. Review.

PMID:
21484381
[PubMed - indexed for MEDLINE]
13.

[Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma].

Chiti A, Orunesu E, Rodari M.

Ann Ital Chir. 2006 May-Jun;77(3):215-22. Review. Italian.

PMID:
17137036
[PubMed - indexed for MEDLINE]
14.

Patient dosimetry in radionuclide therapy: the whys and the wherefores.

Thierens HM, Monsieurs MA, Bacher K.

Nucl Med Commun. 2005 Jul;26(7):593-9. Review.

PMID:
15942479
[PubMed - indexed for MEDLINE]
15.

Patient-specific internal radionuclide dosimetry.

Tsougos I, Loudos G, Georgoulias P, Theodorou K, Kappas C.

Nucl Med Commun. 2010 Feb;31(2):97-106. doi: 10.1097/MNM.0b013e328330626f. Review.

PMID:
20032767
[PubMed - indexed for MEDLINE]
16.

Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing.

DeNardo GL, Juweid ME, White CA, Wiseman GA, DeNardo SJ.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):203-18. Review.

PMID:
11418317
[PubMed - indexed for MEDLINE]
17.

Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry.

Liu A, Williams LE, Wong JY, Raubitschek AA.

Nucl Med Biol. 1998 May;25(4):423-33. Review.

PMID:
9639305
[PubMed - indexed for MEDLINE]
18.

Internal dosimetry for systemic radiation therapy.

Fisher DR.

Semin Radiat Oncol. 2000 Apr;10(2):123-32. Review.

PMID:
10727601
[PubMed - indexed for MEDLINE]
19.

Update in thyroid imaging. The expanding world of thyroid imaging and its translation to clinical practice.

Soto GD, Halperin I, Squarcia M, LomeƱa F, Domingo MP.

Hormones (Athens). 2010 Oct-Dec;9(4):287-98. Review. No abstract available.

PMID:
21112859
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk